Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era

PLoS ONE(2020)10.1371/journal.pone.0234391Source: DataRank Database

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 0.11)OA: goldTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Jaquelyn L. Jahn ORCID,John R. Barber,Misop Han ORCID,Meir J. Stampfer ORCID,Elizabeth A. Platz ORCID

Live enrichment

PubMed:32525914 PMC:PMC7289430 OpenAlex:https://openalex.org/W3035516450

National Cancer Institute

Grant: CA34944

National Cancer Institute

Grant: CA40360

National Heart, Lung, and Blood Institute

Grant: HL26490

National Heart, Lung, and Blood Institute

Grant: HL34595

National Cancer Institute

Grant: CA133891

National Cancer Institute

Grant: CA141298

National Cancer Institute

Grant: P01CA055075

National Cancer Institute

Grant: P30CA006973

National Cancer Institute

Grant: P50CA58236

NCI NIH HHS

Grant: P50 CA058236

NCI NIH HHS

Grant: UM1 CA167552

NCI NIH HHS

Grant: T32 CA009001

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 3P01CA055075-10S1

PROSPECTIVE STUDY OF DIET AND CANCER IN MEN (HEALTH PROFESSIONALS FOLLOWUP)

National Institutes of Health

Grant: 5R01HL034595-02

A RANDOMIZED TRIAL OF ASPIRIN AND MORTALITY IN US MDS

National Institutes of Health

Grant: 3P50CA058236-02S1

SPECIALIZED PGM OF RESEARCH EXCELLENCE/PROSTATE CANCER

National Institutes of Health

Grant: 5UM1CA167552-02

Cancer Epidemiology Cohort in Male Health Professionals

National Institutes of Health

Grant: 5R01CA133891-02

Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression

National Institutes of Health

Grant: 5R01CA141298-04

Growth Factors and Lethal Prostate Cancer Signature

National Institutes of Health

Grant: 5R01CA040360-15

PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP

National Institutes of Health

Grant: 5T32CA009001-38

Training Program in Cancer Epidemiology

FWCI

0.11

Citation Percentile

0.5%

Influential Citations

Citation Trend

2023

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0234391&type=printable

GOLDhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0234391&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0234391&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0234391

journalhttps://doi.org/10.1371/journal.pone.0234391

Fields of Study

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchInflammatory Biomarkers in Disease PrognosisMedicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedAged, 80 and overFollow-Up StudiesHumansKallikreinsMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesProstatectomyProstatic NeoplasmsUnited StatesCohort StudiesProportional Hazards ModelsProstate-Specific Antigen

Keywords

Stage (stratigraphy)ProstatectomyProstate cancerPathologicalMedicineOncologyCancerProstatePathological stagingProportional hazards modelInternal medicineProstate-specific antigenCohortT-stageGynecologyBiologyAged, 80 and overMaleScienceQRProstatic NeoplasmsMiddle AgedPrognosisUnited StatesCohort StudiesHumansKallikreinsProspective StudiesResearch ArticleAgedFollow-Up StudiesNeoplasm StagingProportional Hazards Models

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalities

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era

FAIR Checklist

Authors (7)

Funding (21 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)